<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zabmedvestnik</journal-id><journal-title-group><journal-title xml:lang="ru">Забайкальский медицинский вестник</journal-title><trans-title-group xml:lang="en"><trans-title>Transbaikalian Medical Bulletin</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">1998-6173</issn><publisher><publisher-name>Читинская государственная медицинская академия</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52485/19986173_2022_4_107</article-id><article-id custom-type="elpub" pub-id-type="custom">zabmedvestnik-106</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC REVIEWS</subject></subj-group></article-categories><title-group><article-title>Ишемический инсульт как генетически обусловленное заболевание</article-title><trans-title-group xml:lang="en"><trans-title>Ischemic stroke as a genetical disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ма-Ван-дэ</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Ma-Van-de</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>672000, г. Чита., ул. Горького, 39А</p></bio><bio xml:lang="en"><p>39 A Gorkogo str., Chita, 672000</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Витковский</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vitkovsky</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>672000, г. Чита., ул. Горького, 39А</p></bio><bio xml:lang="en"><p>39 A Gorkogo str., Chita, 672000</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Читинская государственная медицинская академия» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chita State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>02</day><month>08</month><year>2024</year></pub-date><volume>0</volume><issue>4</issue><fpage>107</fpage><lpage>113</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ма-Ван-дэ А.Ю., Витковский Ю.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Ма-Ван-дэ А.Ю., Витковский Ю.А.</copyright-holder><copyright-holder xml:lang="en">Ma-Van-de A., Vitkovsky Y.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.zabmedvestnik.ru/jour/article/view/106">https://www.zabmedvestnik.ru/jour/article/view/106</self-uri><abstract><p>Ишемический инсульт является мультифакториальным заболеванием, патогенез которого тесно связан с генетической предрасположенностью. Результаты проведенных исследований свидетельствуют о повышенном риске развития ишемического инсульта при наличии отягощённого семейного анамнеза. Установлено, что развитие острой церебральной ишемии в возрасте до 65 лет повышает риск возникновения острого нарушения мозгового кровообращения у ближайших родственников в 4 раза. Также известно, что инсульт, возникший в молодом возрасте, в большей степени связан с носительством различных генетических полиморфизмов, нежели с наличием факторов сердечно-сосудистого риска. В обзоре литературы представлены современные данные по острой цереброваскулярной патологии и ее связи с носительством различными полиморфных вариантов генов: ренин-ангиотензин-альдостероновой системы (РААС), генов, регулирующих функцию эндотелия, фолатный обмен, ионные каналы.</p></abstract><trans-abstract xml:lang="en"><p>Ischemic stroke is a multifactorial disease, the pathogenesis of which is closely related to genetic predisposition. The results of the conducted studies indicate an increased risk of ischemic stroke in the presence of an aggravated family history. It has been established that the development of acute cerebral ischemia under the age of 65 increases the risk of acute cerebrovascular accident in the next of kin by 4 times. It is also known that stroke occurring at a young age is more associated with the carriage of various genetic polymorphisms than with the presence of cardiovascular risk factors.</p><p>The literature review presents current data on acute cerebrovascular pathology and its relationship with the carriage of various polymorphic variants of genes: the renin-angiotensin-aldosterone system (RAAS), genes that regulate endothelial function, folate metabolism, and ion channels.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Цереброваскулярные заболевания</kwd><kwd>острое нарушение мозгового кровообращения (ОНМК)</kwd><kwd>ишемический инсульт</kwd><kwd>сердечно-сосудистая патология</kwd><kwd>эндотелиальная дисфункция</kwd><kwd>РААС</kwd><kwd>генетический полиморфизм</kwd><kwd>SNP</kwd><kwd>ионные каналы</kwd><kwd>фолатный обмен</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Cerebrovascular diseases</kwd><kwd>acute stroke</kwd><kwd>ischemic stroke</kwd><kwd>cardiovascular disease</kwd><kwd>endothelial dysfunction</kwd><kwd>RAAS</kwd><kwd>genetic polymorphism</kwd><kwd>SNP</kwd><kwd>ion channels</kwd><kwd>folate metabolism</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">ВОЗ публикует статистику о ведущих причинах смертности и инвалидности во всем мире за период 2000–2019 гг. URL: https://www.who.int/ru/news/item/09-12-2020-who-reveals-leading-causes-of-death-and-disability-worldwide-2000-2019. (дата обращения: 11.10.2022).</mixed-citation><mixed-citation xml:lang="en">WHO publishes statistics on the leading causes of death and disability worldwide for the period 2000–2019. URL: https://www.who.int/ru/news/item/09-12-2020-who-reveals-leading-causes-of-death-and-disability-worldwide-2000-2019. (date of access: 10.11.2022). In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Groppa S., Zota E., Crivorucica I. Accidentul vascular cerebral ischemic: Protocol clinic instituțional. Chisinau. Romanian. 2018.</mixed-citation><mixed-citation xml:lang="en">Groppa S., Zota E., Crivorucica I. Accidentul vascular cerebral ischemic: Protocol clinic instituțional. Chisinau. Romanian. 2018.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Гусев Е. И., Коновалов А.Н., Гехт А. Б. Неврология. Национальное руководство. М.: ГЭОТАР-Медиа. 2019.</mixed-citation><mixed-citation xml:lang="en">Gusev E.I., Konovalov A.N., Gekht A.B. Neurology. National leadership. Moscow: GEOTAR- Media. 2019. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Groppa S. In the Republic of Moldova there is an epidemic of cerebral vascular diseases. Moldova. 2019.</mixed-citation><mixed-citation xml:lang="en">Groppa S. In the Republic of Moldova there is an epidemic of cerebral vascular diseases. Moldova. 2019.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Iwai M., Horiuchi M. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res. 2009. 32(7). 533-536.</mixed-citation><mixed-citation xml:lang="en">Iwai M., Horiuchi M. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res. 2009. 32(7). 533- 536.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wang S. Q., Wu Y. Q., Cheng X. S., Cheng K. C. Relationship between angiotensin-converting enzyme and angiotensinogen gene polymorphism and coronary artery disease. Journal of Nanchang University (Medical Science). 2010. 50(8). 8–11.</mixed-citation><mixed-citation xml:lang="en">Wang S.Q., Wu Y.Q., Cheng X.S., Cheng K.C. Relationship between angiotensin-converting enzyme and angiotensinogen gene polymorphism and coronary artery disease. Journal of Nanchang University (Medical Science). 2010. 50(8). 8–11.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">El Alfy M. S., Ebeid F., Kamal T. M., Eissa D. S., Ismail E. A. R., Mohamed S. H. Angiotensinogen M235T gene polymorphism is a genetic determinant of cerebrovascular and cardiopulmonary morbidity in adolescents with sickle cell disease. Journal of Stroke and Cerebrovascular Diseases. 2019. 28(2). 441–449.</mixed-citation><mixed-citation xml:lang="en">El Alfy M.S., Ebeid F., Kamal T.M., Eissa D.S., Ismail E.A.R., Mohamed S.H. Angiotensinogen M235T gene polymorphism is a genetic determinant of cerebrovascular and cardiopulmonary morbidity in adolescents with sickle cell disease. Journal of Stroke and Cerebrovascular Diseases. 2019. 28(2). 441–449.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Institute for Health Metrics and Evaluation (IHME) (2018). Findings from the Global Burden of Disease Study 2017. http://www.healthdata.org/policy-report/findings-global-burden-disease-study-2017. (Accessed 27. 04. 2022).</mixed-citation><mixed-citation xml:lang="en">Institute for Health Metrics and Evaluation (IHME) (2018). Findings from the Global Burden of Disease Study 2017. http://www.healthdata.org/policy-report/findings-global-burden-disease-study-2017. (date of access: 27. 04. 2022).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Qiu X. J., Liu X., et al. Polymorphism of angiotensinogen gene M235T in myocardial infarction and brain infarction: a meta-analysis. Gene. 2013. 529 (1). 73-79.</mixed-citation><mixed-citation xml:lang="en">Qiu X.J., Liu X., et al. Polymorphism of angiotensinogen gene M235T in myocardial infarction and brain infarction: a meta-analysis. Gene. 2013. 529 (1). 73-79.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Isordia-Salas I., Santiago-Germán D., Cerda-Mancillas M.C., et al. Gene polymorphisms of angiotensin-converting enzyme and angiotensinogen and risk of idiopathic ischemic stroke. Gene. 2019. 688. 163-170.</mixed-citation><mixed-citation xml:lang="en">Isordia-Salas I., Santiago-Germán D., Cerda-Mancillas M.C., et al. Gene polymorphisms of angiotensin-converting enzyme and angiotensinogen and risk of idiopathic ischemic stroke. Gene. 2019. 688. 163-170.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bhushan S., Xiao Z., Gao K., et al. Role and Interaction Between ACE1, ACE2 and Their Related Genes in Cardiovascular Disorders. Curr Probl Cardiol. 2022. 2:101162.</mixed-citation><mixed-citation xml:lang="en">Bhushan S., Xiao Z., Gao K., et al. Role and Interaction Between ACE1, ACE2 and Their Related Genes in Cardiovascular Disorders. Curr Probl Cardiol. 2022. 2:101162.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Shin B.S., Oh S.Y., Kim Y.S., Kim K.W. The paraoxonase gene polymorphism in stroke patients and lipid profile. Acta Neurol Scand. 2008. 117. 237-243.</mixed-citation><mixed-citation xml:lang="en">Shin B.S., Oh S.Y., Kim Y.S., Kim K.W. The paraoxonase gene polymorphism in stroke patients and lipid profile. Acta Neurol Scand. 2008. 117. 237-243.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Goyal A., Saluja A., Saraswathy KN., Bansal P., Dhamija RK. Role of ACE Polymorphism in Acute Ischemic Stroke. Neurol India. 2021. 69(5). 1217-1221.</mixed-citation><mixed-citation xml:lang="en">Goyal A., Saluja A., Saraswathy KN., Bansal P., Dhamija RK. Role of ACE Polymorphism in Acute Ischemic Stroke. Neurol India. 2021. 69(5). 1217-1221.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Шишкин А.Н., Лындина М.Л. Эндотелиальная дисфункция и артериальная гипертензия. Артериальная Гипертензия. 2008. 14(4). 315-319.</mixed-citation><mixed-citation xml:lang="en">Shishkin A.N., Lyndina M.L. Endothelial dysfunction and arterial hypertension. Arterial hypertension. 2008.14(4). 315-319. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Musa A., Abir R. Polymorphism in Endothelin-1 Gene: An Overview. Current Clinical Pharmacology. 2016. 11(3). 191-210.</mixed-citation><mixed-citation xml:lang="en">Musa A., Abir R. Polymorphism in Endothelin-1 Gene: An Overview. Current Clinical Pharmacology. 2016. 11(3). 191-210.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar A., Vivekanandhan S., Srivastava A., Tripathi M., Padma Srivastava M.V., Saini N., et al. Association between angiotensin converting enzyme gene insertion/deletion polymorphism and ischemic stroke in north Indian population: A case-control study and meta-analysis. Neurol Res. 2014. 36. 786-794.</mixed-citation><mixed-citation xml:lang="en">Kumar A., Vivekanandhan S., Srivastava A., Tripathi M., Padma Srivastava M.V., Saini N., et al. Association between angiotensin converting enzyme gene insertion/deletion polymorphism and ischemic stroke in north Indian population: A case-control study and meta-analysis. Neurol Res. 2014. 36. 786-794.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Estrada V., Egido J., Fernández‐Durango R., Fernández Cruz, A., Moya, J., Téllez, M. J. High plasma levels of endothelin‐1 and atrial natriuretic peptide in patients with acute ischemic stroke. American Journal of Hypertension. 1994. 7(12). 1085–1089.</mixed-citation><mixed-citation xml:lang="en">Estrada V., Egido J., Fernández ‐ Durango R., Fernández Cruz, A., Moya, J., Téllez, M. J. High plasma levels of endothelin ‐ 1 and atrial natriuretic peptide in patients with acute ischemic stroke. American Journal of Hypertension. 1994. 7(12). 1085–1089.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bartesaghi S, Radi R. Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration. Redox Biol. 2018. 14 (4). 618-625.</mixed-citation><mixed-citation xml:lang="en">Bartesaghi S, Radi R. Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration. Redox Biol. 2018. 14 (4). 618-625.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ko N. U., Rajendran P., Kim H., et.al. Endothelial nitric oxide synthase polymorphism (-786T- &gt;C) and increased risk of angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008. 39 (4). 1103-1108.</mixed-citation><mixed-citation xml:lang="en">Ko N. U., Rajendran P., Kim H., et.al. Endothelial nitric oxide synthase polymorphism (-786T- &gt;C) and increased risk of angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008. 39 (4). 1103-1108.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">An, L., Shen, Y., Chopp, M., Zacharek, A. Deficiency of Endothelial Nitric Oxide Synthase (eNOS) Exacerbates Brain Damage and Cognitive Deficit in A Mouse Model of Vascular Dementia. Aging and disease. 2021. 12(3). 732–746.</mixed-citation><mixed-citation xml:lang="en">An L., Shen, Y., Chopp, M., Zacharek, A. Deficiency of Endothelial Nitric Oxide Synthase (eNOS) Exacerbates Brain Damage and Cognitive Deficit in A Mouse Model of Vascular Dementia. Aging and disease. 2021. 12(3). 732–746.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Huang L.W, Li L.L, Li J., Chen X.R, Yu M. Association of the methylenetetrahydrofolate reductase (MTHFR) gene variant C677T with serum homocysteine levels and the severity of ischemic stroke: a case-control study in the southwest of China. J Int Med Res. 2022. 50(2):3000605221081632.</mixed-citation><mixed-citation xml:lang="en">Huang L.W, Li L.L, Li J., Chen X.R, Yu M. Association of the methylenetetrahydrofolate reductase (MTHFR) gene variant C677T with serum homocysteine levels and the severity of ischemic stroke: a case-control study in the southwest of China. J Int Med Res. 2022. 50(2):3000605221081632.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Malinow M.R., Bostom A.G., Kraus R.M. Circulation. 1999. 99. 178–182</mixed-citation><mixed-citation xml:lang="en">Malinow M.R., Bostom A.G., Kraus R.M. Circulation. 1999. 99. 178–182</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Zaric B.L., Obradovic M., V Bajic., Haidara M.A., Jovanovic M., Isenovi E.R. Homocysteine and Hyperhomocysteinaemia. Curr. Med. Chem. 2019. 26 (16). 2948–2961.</mixed-citation><mixed-citation xml:lang="en">Zaric B.L., Obradovic M., V Bajic., Haidara M.A., Jovanovic M., Isenovi E.R. Homocysteine and Hyperhomocysteinaemia. Curr. Med. Chem. 2019. 26 (16). 2948–2961.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Степанова Т.В., Иванов А.Н., Терешкина Н.Е. Маркеры эндотелиальной дисфункции: патогенетическая роль и диагностическое значение (обзор литературы). Клиническая лабораторная диагностика. 2019. 34–41.</mixed-citation><mixed-citation xml:lang="en">Stepanova T.V., Ivanov A.N., Tereshkina N.E. Markers of endothelial dysfunction: pathogenetic role and diagnostic value (literature review). Clinical laboratory diagnostics. 2019. 34–41. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar P., Mishra A., Prasad MK., Verma V., Kumar A. Relationship of Methylenetetrahydrofolate Reductase (MTHFR) C677T Variation With Susceptibility of Patients With Ischemic Stroke: A Meta-Analysis. Cureus. 2022. 14(8):e28218.</mixed-citation><mixed-citation xml:lang="en">Kumar P., Mishra A., Prasad M.K., Verma V., Kumar A. Relationship of Methylenetetrahydrofolate Reductase (MTHFR) C677T Variation with Susceptibility of Patients with Ischemic Stroke: A Meta-Analysis. Cureus. 2022. 14(8):e28218.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Wei. L.K., Au A., Menon S., et al. Polymorphisms of MTHFR, eNOS, ACE, AGT, ApoE, PON1, PDE4D, and Ischemic Stroke: Meta-Analysis. J Stroke Cerebrovasc Dis. 2017. 26(11). 2482- 2493.</mixed-citation><mixed-citation xml:lang="en">Wei. L.K., Au A., Menon S., et al. Polymorphisms of MTHFR, eNOS, ACE, AGT, ApoE, PON1, PDE4D, and Ischemic Stroke: Meta-Analysis. J Stroke Cerebrovasc Dis. 2017. 26(11). 2482- 2493.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Смольнова Т.Ю., Нечаева Г.И., Логинова Е.Н. Роль снижения экспрессии гена CACNA1C в развитии некоторых состояний в практике врача. Клиническая медицина. 2020. 13-19.</mixed-citation><mixed-citation xml:lang="en">Smolnova T.Yu., Nechaeva G.I., Loginova E.N. The role of reduced CACNA1C gene expression in the development of certain conditions in physician practice. Clinical medicine. 2020. 13-19. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Rodan L.H., Spillmann R.C., Kurata H.T. Phenotypic expansion of CACNA1C-associateddisorders to include isolated neurological manifestations. Genet Med. 2021. 23(10). 1922-1932.</mixed-citation><mixed-citation xml:lang="en">Rodan L.H., Spillmann R.C., Kurata H.T. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations. Genet Med. 2021. 23(10). 1922-1932.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Smedler E., Pålsson E., Hashimoto K., Landén M. Association of CACNA1C polymorphisms with serum BDNF levels in bipolar disorder. Br J Psychiatry. 2021. 218(2). 77-79.</mixed-citation><mixed-citation xml:lang="en">Smedler E., Pålsson E., Hashimoto K., Landén M. Association of CACNA1C polymorphisms with serum BDNF levels in bipolar disorder. Br J Psychiatry. 2021. 218(2). 77-79.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Chen M., Jiang Q., Zhang L. CACNA1C Gene rs1006737 Polymorphism Affects Cognitive Performance in Chinese Han Schizophrenia. Neuropsychiatr Dis Treat. 2022.18. 1697-1704.</mixed-citation><mixed-citation xml:lang="en">Chen M., Jiang Q., Zhang L. CACNA1C Gene rs1006737 Polymorphism Affects Cognitive Performance in Chinese Han Schizophrenia. Neuropsychiatr Dis Treat. 2022.18. 1697-1704.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang H., Pushkarev B., Zhou J., et al. CACNA1C rs1006737 SNP increases the risk of essential hypertension in both Chinese Han and ethnic Russian people of Northeast Asia. Medicine (Baltimore). 2021. 100(8):e24825.</mixed-citation><mixed-citation xml:lang="en">Zhang H., Pushkarev B., Zhou J., et al. CACNA1C rs1006737 SNP increases the risk of essential hypertension in both Chinese Han and ethnic Russian people of Northeast Asia. Medicine (Baltimore). 2021. 100(8):e24825.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Korte N., Ilkan Z., Pearson CL., et al. The Ca2+-gated channel TMEM16A amplifies capillary pericyte contraction and reduces cerebral blood flow after ischemia. J Clin Invest. 2022. 132(9):e154118.</mixed-citation><mixed-citation xml:lang="en">Korte N., Ilkan Z., Pearson C.L., et al. The Ca2+-gated channel TMEM16A amplifies capillary pericyte contraction and reduces cerebral blood flow after ischemia. J Clin Invest. 2022. 132(9):e154118.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Maiques O., Macià A., Moreno S., et al. Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma. Br J Dermatol. 2017.176 (5). 1247–1258.</mixed-citation><mixed-citation xml:lang="en">Maiques O., Macià A., Moreno S., et al. Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma. Br J Dermatol. 2017.176 (5). 1247–1258.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
